Spots Global Cancer Trial Database for A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors
Official Title: A Phase 1a Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors
Study ID: NCT02414516
Conditions
Interventions
Study Description
Brief Summary: This Phase 1a, single center, open-label, repeat dose study will evaluate the safety, efficacy, and Pharmacokinetics of ascending doses of OBP-801 in patients with advanced solid tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
